29
Abstract 30 Background 31 Human papillomavirus (HPV) is a common sexually transmitted infection that is implicated in 99.7% 32 of cervical cancers and several other cancers that affect both men and women. Despite the role that 33
HPV plays in an estimated 5% of all cancers and the evolving role of HPV vaccination and testing in 34 protecting the public against these cancers, preliminary research in New Zealand health care 35 professionals suggest knowledge about HPV may not be sufficient.
Methods

37
A total of 230 practice nurses, smear takers and other clinical and laboratory staff who attended a 38 range of training events completed a cross-sectional survey between April 2016 and July 2017. The 39 survey explored four broad areas: demographics and level of experience, HPV knowledge (general 40 HPV knowledge, HPV triage and test of cure (TOC) knowledge and HPV vaccine knowledge), attitudes 41 towards the HPV vaccine and self-perceived adequacy of HPV knowledge.
42 Results
43
The mean score on the general HPV knowledge questions was 13.2 out of 15, with only 25.2% of 44 respondents scoring 100%. In response to an additional question, 14.0% thought (or were unsure) 45 that HPV causes HIV/AIDS. The mean score on the HPV Triage and TOC knowledge questions was 7.4 46 out of 10, with only 9.1% scoring 100%. The mean score on the HPV vaccine knowledge questions 47 was 6.0 out of 7 and 44.3% scored 100%. Only 62.6% of respondents agreed or strongly agreed that 48 they were adequately informed about HPV, although 71.8% agreed or strongly agreed that they 49 could confidently answer HPV-related questions asked by patients. Multivariate Table 2 and excluding the   167 question about HIV/AIDS), the mean score achieved by participants was 13.2 (standard deviation 168 (SD) 2.0) and the median score was 14 (range 0-15, interquartile range (IQR) 13-15), with 25.2% 169 (N=58) achieving 100%. One individual did not answer any questions correctly.
170 Out of a maximum knowledge score of 10 (see individual questions in Table 2 ), the mean score 186 achieved by the participants was 7.4 (SD 2.1) and the median score was 8 (range 0-10, IQR 6-9), with 187 9.1% (N=21) achieving 100%. Three individuals had no correct answers.
188
The following questions were answered incorrectly most often: Out of a maximum knowledge score of 7 (see individual questions in Table 2 ), the mean score 203 achieved by the participants was 6.0 (SD 1.2) and the median score was 6 (range 0-7, IQR 5-7), with 204 44.3% (N=102) achieving 100%. One individual had no answers correct.
205
The following questions were answered incorrectly most often: The HPV vaccine offers protection 206 against genital warts (32.2% answered incorrectly or weren't sure); The HPV vaccines offer 207 protection against most cervical cancers (19.6%); The HPV vaccines are most effective if given to 208 people who have never had sex (17.8%). In addition, more than 10% of participants incorrectly 209 thought (or weren't sure) that the recommended number of HPV vaccine doses was not three and 210 that someone who has had the HPV vaccine cannot develop cervical cancer.
211
Factors influencing level of HPV knowledge 212 Table 4 ), 22.6% (N=52) were undecided, while 13.0% (N=30) disagreed or strongly 267 disagreed (there were 4 (1.7%) blank responses).
268
Despite this, 71.8% (N=165) respondents agreed or strongly agreed that they could confidently 269 answer HPV related questions asked by patients (see Table 4 ). A further 17.8% (N=41) were 270 undecided and 8.2% (N=19) disagreed or strongly disagreed (there were 5 (2.2%) blank responses).
271
Independent t-tests confirmed that the knowledge scores for general HPV knowledge, triage and 272 test of cure knowledge and HPV vaccine knowledge were all significantly higher for those 273 participants who felt they were adequately informed than in those who did not feel they were or 274 who were unsure (p<0.01). The same was found for the question about feeling confident in 275 answering patient questions.
276
Feeling adequately informed and feeling confident in answering patient questions were both related 277 to having ever taken a smear, years since training, and to a much lesser extent, current role (data 278 not shown). Therefore, the relationship between self-perceived adequacy and knowledge was 279 explored further in multivariate analysis using binary logistic regression (Table 5) .
280
Feeling adequately informed was independently predicted by HPV vaccine knowledge after 281 adjustment for the other predictors, while the association with HPV knowledge and Triage and TOC 282 knowledge disappeared after adjustment. All three knowledge domains independently predicted 283 confidence in answering patient questions, even after adjustment for the other predictors. 
305
General HPV knowledge was the highest overall but around a quarter of respondents were unaware 306 that having sex at an early age increases the risk of getting HPV. A quarter of respondents were also 307 unaware that HPV is so common that most sexually active people will be exposed to it in their 308 
387
The need for education indicated by the knowledge scores was further reinforced by the fact that 388 over a third of respondents did not agree that they felt adequately informed about HPV and that 389 being adequately informed and feeling confident in responding to patients' questions were both 390 associated with knowledge. Suggestions for training were proposed by some of the respondents.
391
One promising suggestion, which was also proposed by UK practice nurses, 12 was for online training.
392
This would provide a low-cost way to update changes to the vaccination and/or screening 393 programmes and guidelines in a format that would be easily accessible to many staff whilst requiring 394 relatively little time commitment to complete. HPV vaccination online training was developed by the 395 Immunisation Advisory Committee (IMAC) and was released in August 2017 18 . This may address 396 some of the knowledge issues associated with vaccination identified in this study, but additional 397 online training regarding screening and test of cure is needed.
398
Our survey is the first to be conducted in NZ that explores health practitioner knowledge and 399 understanding about HPV, the vaccine and the role of HPV testing in the cervical screening 400 programme and it contributes to the international picture about HPV knowledge that is emerging. It 401 is evident from our findings and those from other countries, that more education is required to 402 ensure that misinformation, stigma and widening inequalities do not inadvertently result from 403 interactions between health practitioners and the public. Data Availability Statement 
